脂质体
纳米载体
膜
药物输送
阳离子脂质体
共焦显微镜
生物物理学
内化
赫拉
脂质双层
活力测定
化学
细胞
细胞膜
纳米技术
细胞生物学
材料科学
生物化学
转染
生物
基因
作者
Adrià Botet-Carreras,Manel Bosch Marimon,Rubén Millán‐Solsona,Eva Aubets,Carlos J. Ciudad,Verónique Noé,M. Teresa Montero,Òscar Domènech,Jordi Hernández-Borrell
标识
DOI:10.1016/j.colsurfb.2022.112968
摘要
In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe physicochemical changes on the cell surface and confocal microscopy to determine how the liposomes interact with cell membranes and released their load. In addition, we performed viability assays using methotrexate as an active drug to obtain proof of concept of the formulation´s capacity to function as a drug delivery-system. The interaction of engineered liposomes with living cells corroborates the information obtained using model membranes and supports the capacity of the engineered liposomal formulation to serve as a potential nanocarrier.
科研通智能强力驱动
Strongly Powered by AbleSci AI